Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-27

FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for carbidopa-levodopa (Zydus Pharmaceuticals USA Inc.). The drug is used to treat Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa and Levodopa (Carbidopa and Levodopa)

Snippet

SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)